KR20010031762A - 유전자요법을 위한 과열 유도 발현 벡터 및 그의 이용 방법 - Google Patents

유전자요법을 위한 과열 유도 발현 벡터 및 그의 이용 방법 Download PDF

Info

Publication number
KR20010031762A
KR20010031762A KR1020007004827A KR20007004827A KR20010031762A KR 20010031762 A KR20010031762 A KR 20010031762A KR 1020007004827 A KR1020007004827 A KR 1020007004827A KR 20007004827 A KR20007004827 A KR 20007004827A KR 20010031762 A KR20010031762 A KR 20010031762A
Authority
KR
South Korea
Prior art keywords
promoter
expression
cells
gene
cell
Prior art date
Application number
KR1020007004827A
Other languages
English (en)
Korean (ko)
Inventor
짱톰
저너유진더블유.
해리스데이비드티.
헐쉬이반
Original Assignee
추후제출
디 애리조나 보드 오브 리젠츠 온 비해프 오브 더 유니버시티 오브 애리조나
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 추후제출, 디 애리조나 보드 오브 리젠츠 온 비해프 오브 더 유니버시티 오브 애리조나 filed Critical 추후제출
Publication of KR20010031762A publication Critical patent/KR20010031762A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020007004827A 1997-11-03 1998-11-03 유전자요법을 위한 과열 유도 발현 벡터 및 그의 이용 방법 KR20010031762A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6408897P 1997-11-03 1997-11-03
US60/064,088 1997-11-03
PCT/US1998/023387 WO1999023216A2 (fr) 1997-11-03 1998-11-03 Vecteurs d'expression inductible par hyperthermie utiles pour la therapie genique et procedes d'utilisation de ceux-ci

Publications (1)

Publication Number Publication Date
KR20010031762A true KR20010031762A (ko) 2001-04-16

Family

ID=22053477

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007004827A KR20010031762A (ko) 1997-11-03 1998-11-03 유전자요법을 위한 과열 유도 발현 벡터 및 그의 이용 방법

Country Status (9)

Country Link
EP (1) EP1029041A2 (fr)
JP (1) JP2001521740A (fr)
KR (1) KR20010031762A (fr)
CN (1) CN1299411A (fr)
AU (1) AU1377299A (fr)
BR (1) BR9813917A (fr)
CA (1) CA2308575A1 (fr)
IL (1) IL135943A0 (fr)
WO (1) WO1999023216A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951765A1 (de) * 1999-10-27 2001-05-03 Thomas Schweder Wirts-Vektor-Systeme zur Überproduktion von thermolabilen Enzymen psychrophiler Organismen
US6579522B1 (en) 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
US7285414B2 (en) 2000-09-26 2007-10-23 Emory University Viruses targeted to hypoxic cells and tissues
CA2423833C (fr) * 2000-09-26 2011-02-22 Emory University Virus diriges sur des cellules et des tissus hypoxiques
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
EP1541674B9 (fr) 2002-06-18 2011-09-14 Eisai R&D Management Co., Ltd. Adipocytes de culture primaire utilises en therapie genique
AU2003278079A1 (en) * 2002-10-14 2004-05-04 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
JP2008048601A (ja) * 2004-06-15 2008-03-06 Nippon Kosei Kagaku Kenkyusho:Kk 治療に有用な産物の生産法およびシステム
EP1879622A2 (fr) * 2005-05-03 2008-01-23 Veterinärmedizinische Universität Wien Capsules permeables
RU2499599C2 (ru) * 2007-09-28 2013-11-27 Интрексон Корпорейшн Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение
CN103667345B (zh) * 2013-12-02 2015-10-28 东南大学 一种抗肿瘤基因磁性复合纳米颗粒及制备方法
WO2017133175A1 (fr) * 2016-02-04 2017-08-10 Nanjing Legend Biotech Co., Ltd. Cellules mammifères génétiquement modifiées pour thérapie anticancéreuse
CN108913661A (zh) * 2018-06-22 2018-11-30 安徽 一种人体研究用造血干细胞的制备和提取方法
CN114317588B (zh) * 2020-09-29 2023-06-27 中国农业科学院生物技术研究所 一种作物高温响应型基因组精准甲基化调控回路
IT202200000788A1 (it) * 2022-01-19 2023-07-19 Bruno Cell S R L Induzione sensibile alla temperatura del programma miogenico e/o adipogenico in cellule per la produzione di tessuto muscolare e/o adiposo
CN116536349B (zh) * 2023-05-22 2024-02-20 安徽农业大学 一种大豆GmMLP34基因在调控植物耐高温性上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991770A (en) * 1974-01-24 1976-11-16 Leveen Harry H Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation
EP0299127A1 (fr) * 1987-07-16 1989-01-18 IntraCel Corporation Procédé pour exprimer des gènes recombinants, stimulés par une protéine activatrice, exprimée par induction
EP0455424A3 (en) * 1990-05-02 1992-04-29 Merck & Co. Inc. Mammalian inducible promoter cascade system
FR2717187B1 (fr) * 1994-03-10 1996-05-31 Transgene Sa Usage combiné de deux cassettes d'expression pour la production d'une protéine d'intérêt.

Also Published As

Publication number Publication date
EP1029041A2 (fr) 2000-08-23
CN1299411A (zh) 2001-06-13
AU1377299A (en) 1999-05-24
CA2308575A1 (fr) 1999-05-14
BR9813917A (pt) 2001-10-30
JP2001521740A (ja) 2001-11-13
WO1999023216A3 (fr) 1999-08-05
WO1999023216A2 (fr) 1999-05-14
IL135943A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
JP3847334B2 (ja) ＤＮＡ損傷剤およびр５３を含有する組成物
US10538744B2 (en) Use of adenovirus and nucleic acids coding therefor
KR20010031762A (ko) 유전자요법을 위한 과열 유도 발현 벡터 및 그의 이용 방법
Zhu et al. Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo
JPH10503361A (ja) 組換えｐ５３アデノウイルス方法と組成物
JPH10509880A (ja) 組織特異的複製のためのベクター
US20080292592A1 (en) Oncolytic Adenovirus Armed with Therapeutic Genes
AU1755299A (en) Vector for tissue-specific replication and gene expression
US20070244064A1 (en) Methods and compositions to induce antitumor response
JP2004501650A (ja) 複製欠損アデノウイルスｔｎｆベクター
JP2002506651A (ja) 多重遺伝子ベクター
JP4361954B2 (ja) アデノウィルス核酸を含有する医薬用組成物
US6709858B1 (en) Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
US7056897B2 (en) Inducible expression vectors and methods of use thereof
Kouraklis Gene therapy for cancer
Halloran et al. Gene therapy for pancreatic cancer—current and prospective strategies
WO1997016547A1 (fr) VECTEURS D'EXPRESSION ADENOVIRAUX ANTISENS DU K-ras ET LEUR APPLICATION EN THERAPIE ANTICANCEREUSE
Palapattu et al. GENE THERAPY FOR PROSTATE CANCER: New Perspectives on an Old Problem
US7098191B2 (en) Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
WO2005037322A1 (fr) Médicament de traitement anticancéreux
MXPA00004293A (en) Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
JP7406263B2 (ja) 改変アデノウイルス及びこれを含む医薬
Clayman Gene therapy for head and neck cancer
WO2021020554A1 (fr) Méthode de traitement du cancer du foie à l'aide de l'utilisation associée du gène reic/dkk-3 et d'un agent anti-tumoral
AU2015201828B2 (en) Novel use of adenoviruses and nucleic acids coding therefor

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid